Cartesian Therapeutics (RNAC) EBIT Margin (2015 - 2026)
Cartesian Therapeutics (RNAC) reported EBIT Margin of -33973.08% for Q1 2026, down 31983.17 percentage points from -1989.91% a year earlier and down 25669.06 percentage points from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBIT Margin (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics posted EBIT Margin of -5127.10%, down 5014.29 percentage points from FY2024.
- EBIT Margin has a five-year change of -4784.74 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -112.81% in FY2024 (+219.51 pp), -332.32% in FY2023 (-345.44 pp), 13.12% in FY2022 (+18.53 pp) and -5.40% in FY2021 (+336.95 pp).
- The Q1 2026 figure ranks as the lowest quarterly EBIT Margin since Q2 2019.
- Year over year, EBIT Margin gained in 1 of the last six quarters, with an average year-over-year change of -7528.29 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q2 2024 (a gain of 396.21 percentage points); the low point was Q1 2026 (a drop of 31983.17 percentage points).
- Per Business Quant data, the three quarters before Q1 2026 came in at -8304.01% (Q4 2025), -4660.62% (Q3 2025) and -7319.13% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -33,973.08% |
| Dec 31, 2025 | -8,304.01% |
| Sep 30, 2025 | -4,660.62% |
| Jun 30, 2025 | -7,319.13% |
| Mar 31, 2025 | -1,989.91% |
| Sep 30, 2024 | -4,541.34% |
| Jun 30, 2024 | 41.13% |
| Mar 31, 2024 | -228.56% |
| Dec 31, 2023 | -439.54% |
| Sep 30, 2023 | -199.44% |
| Jun 30, 2023 | -355.08% |
| Mar 31, 2023 | -309.55% |
| Dec 31, 2022 | -50.59% |
| Sep 30, 2022 | -7.72% |
| Jun 30, 2022 | 35.29% |
| Mar 31, 2022 | 31.69% |
| Dec 31, 2021 | 13.62% |
| Sep 30, 2021 | -8.06% |
| Jun 30, 2021 | 2.30% |
| Mar 31, 2021 | -64.78% |
API Access
Cartesian Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();